Magnetic resonance imaging of pancreatic metastases from renal cell carcinoma

Amrita Sikka, Sharon Z. Adam, Cecil Wood, Frederick Hoff, Carla B. Harmath, Frank H. Miller*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Pancreatic metastases are rare but are thought to be most commonly from renal cell carcinoma (RCC). These metastases can present many years after the initial tumor is resected, and accordingly, these patients require prolonged imaging follow-up. Although the computed tomographic findings of these metastases have been extensively reviewed in the literature, little has been written about the magnetic resonance imaging appearance of these metastases. Pancreatic metastases from RCC are typically T1 hypointense and T2 hyperintense. After intravenous administration of gadolinium, they are typically hypervascular and less commonly hypovascular. Chemical shift and diffusion-weighted imaging can aid in the diagnosis of these metastases.

Original languageEnglish (US)
Pages (from-to)945-953
Number of pages9
JournalClinical Imaging
Volume39
Issue number6
DOIs
StatePublished - Nov 2015

Keywords

  • MRI
  • Metastases
  • Pancreas
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Magnetic resonance imaging of pancreatic metastases from renal cell carcinoma'. Together they form a unique fingerprint.

Cite this